Jing Liu
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.5%
- Circular RNAs in diseases
- RNA modifications and cancer
- CRISPR and Genetic Engineering
- Genomics and Phylogenetic Studies
- Epigenetics and DNA Methylation
Papers in
- Cancer Research 116
- MicroRNA in disease regulation 59
- Cancer-related molecular mechanisms research 43
- Nephrology 47
Jing Liu
1.1k papers receiving 22.5k citations
Hit Papers
Peers
Comparison fields: 5 of 210
- Cancer Research 2.6k
- Molecular Biology 9.6k
- Nephrology 920
- Immunology 2.1k
- Complementary and alternative medicine 761
Countries citing papers authored by Jing Liu
This map shows the geographic impact of Jing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Liu more than expected).
Fields of papers citing papers by Jing Liu
This network shows the impact of papers produced by Jing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Liu. The network helps show where Jing Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 10 | |
| 16 | 2021 | 12 | |
| 17 | Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Luteum Hit paper breakdown → | 2019 | 234 |
| 18 | 2019 | 4 | |
| 19 | 2019 | 34 | |
| 20 | 2016 | 84 |
About Jing Liu
Jing Liu is a scholar working on Cancer Research, Nephrology, Molecular Biology, Immunology and Virology, having authored 1.2k papers that have together received 22.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (59 papers), Cancer-related molecular mechanisms research (43 papers), RNA modifications and cancer (41 papers), Epigenetics and DNA Methylation (34 papers), Circular RNAs in diseases (32 papers), Liver Disease Diagnosis and Treatment (30 papers), Molecular Biology Techniques and Applications (28 papers) and Immune Cell Function and Interaction (28 papers). The work is most often cited by research in Cancer Research (2.6k citations), Molecular Biology (9.6k citations), Nephrology (920 citations), Immunology (2.1k citations) and Complementary and alternative medicine (761 citations). Jing Liu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jun Yu, Songnian Hu, Jiabin Tang, Mengliang Cao, Tian Liu, Xiaman Wang, Linda L. LaGasse, Aili He, Barry M. Lester and David B. Weiner. Their work appears in journals such as Scientific Reports, PLoS ONE, Forensic Science International Genetics, Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.